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Nosocomial
Dengue by
Mucocutaneous
Transmission
To the Editor: Wagner and col-
leagues report nosocomial dengue
transmitted by needlestick and note
that it is the fourth case of nosocomi-
al dengue to their knowledge (1). In
the same issue of Emerging Infectious
Diseases, Nemes and colleagues
report a separate case of nosocomial
dengue also transmitted by needle-
stick (2). Three other cases of nosoco-
mial dengue transmission by needle-
stick have previously been published
(3–5).
We have recently published a case
of nosocomial dengue infection that
was transmitted by mucocutaneous
exposure to blood from a febrile trav-
eler who had recently returned from
Peru (6). During phlebotomy, a
healthcare worker was splashed in the
face with the traveler’s blood. Both
the traveler and the healthcare worker
were subsequently found to have
dengue fever with dengue virus type
3. This route of infection is biologi-
cally plausible because infection
through mucosal surfaces (intranasal
and oral routes) has been shown pos-
sible for arboviruses (7). In our
review of the literature, we also found
a report of dengue virus transmission
by bone marrow transplantation (8).
Other cases of transmission of dengue
virus without a mosquito vector have
occurred in 5 reported instances of
infection in newborns as a result of
intrapartum or vertical transmission
from mother to child (9–12).
We agree that nosocomial trans-
mission may become more common
in temperate areas as more travelers
return home with acute dengue fever.
As Wagner and colleagues pointed
out, travelers visiting Southeast Asia
have the greatest risk of acquiring
dengue infections because of the high
endemicity of these viruses there. Our
report further illustrates the occur-
rence of dengue infection in the
Americas (13) and the risk for dengue
to travelers visiting this region.
Among 33 returned travelers with
dengue infection reported in the
United States in 1999 and 2000, 20
had acquired infection in the
Caribbean islands (12 cases) or
Central or South America (8 cases)
(14). Clinicians and laboratorians
should be alert to the possibility of
acquiring infection with a dengue
virus after needlestick or mucocuta-
neous blood exposure. The magnitude
of nosocomial transmission in
dengue-endemic areas is unknown
and more difficult to assess because
healthcare workers may be exposed to
dengue virus–infected mosquitoes
outside the clinical setting. 
Lin H. Chen*† 
and Mary E. Wilson*†
*Mount Auburn Hospital, Cambridge,
Massachusetts, USA; and †Harvard
Medical School, Boston, Massachusetts,
USA
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Barriers to
Creutzfeldt-Jakob
Disease Autopsies,
California
To the Editor: The recent article
by Louie et al. underscores a more
general disparity between the need for
autopsies in potential infectious dis-
ease deaths and our present national
capacity (1). In addition to confirming
Creutzfeldt-Jakob disease (CJD) and
allowing the differentiation of classic
and variant CJD, autopsies identify
previously undetected infections, dis-
cover causative organisms in unex-
plained infectious disease deaths, and
provide insights into the pathogenesisLETTERS
of new or unusual infections (2,3).
This information is essential for pub-
lic health and medical interventions.
As outlined by Louie et al., hospi-
tal autopsy rates have dropped to sin-
gle digits, and concerns by patholo-
gists about occupational risks and
biosafety have likely contributed to
this decline. Currently, the last strong-
hold of autopsy expertise is forensic
pathology (4). However, the
medicolegal death investigative sys-
tem does not have jurisdiction over all
potential infectious disease deaths nor
is it adequately supported to assume
the cases that are missed by our pres-
ent hospital autopsy system.
Additionally, many medicolegal and
hospital autopsy facilities with outdat-
ed or poorly-designed air flow sys-
tems are ill suited to handle autopsies
when infectious disease is suspected
(5). Air-handling systems can be
expensive to fix.
Reference centers such as the
National Prion Disease Pathology
Surveillance Center, while providing
diagnostic expertise, fail to surmount
the biosafety obstacles (real and per-
ceived) that prevent pathologists from
enthusiastically performing autopsies
on those who died of potential infec-
tious diseases, including prion dis-
eases. One potential solution is the
creation of regional centers of excel-
lence for infectious disease autopsies
that could operate in conjunction with
a mobile containment autopsy facility
(5,6). Such centers could provide
diagnostic expertise as well as
biosafety capacity.
Kurt B. Nolte* 
*University of New Mexico, Albuquerque,
New Mexico, USA
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Q Fever Wildlife
Reservoir 
To the Editor: To the list of
zoonotic infections with wildlife
sources reported by Kruse et al. (1), I
would add Coxiella burnetii infection
because of its global impact, exten-
sive presence in the animal kingdom,
and potential for use as an agent of
bioterrorism (2). C. burnetii causes Q
fever, a self-limited disease that usual-
ly appears as undifferentiated fever,
pneumonia, or hepatitis, but which
may progress into chronic disease,
especially endocarditis, among sus-
ceptible persons. Q fever is endemic
worldwide in domestic mammals,
especially ungulates (cattle, sheep,
and goats), but also has been found in
wild mammals, birds, and arthropods.
The transmission of Q fever to
humans from wild rabbits was docu-
mented in the 1980s (3). More recent-
ly, a study showed seroprevalence of
Q fever ranging from 7% to 53% in
brown rats (Rattus norvegicus) in
Oxfordshire, which suggests that they
are a possible reservoir for C. burnetii
in the United Kingdom. The study
also speculated why cats, as frequent
predators of rats, are important in
maintaining the transmission cycle of
the disease (4).
A case-control study published in
2001 (5) attempted to define the risk
factors for an increasein the incidence
of Q fever in French Guiana in 1996.
The study found no link between Q
fever and domestic ungulates, the
usual source of outbreaks. The role of
pets, basically dogs and cats, as a
reservoir was also excluded.
Multivariate analysis showed that liv-
ing in close proximity to the forest,
exposure to wild animals (including
bats), and working in public trade or
public works were all associated with
infection. A strong correlation
between large amounts of rainfall and
higher incidence of Q fever was found
also. All of these findings suggested a
wild reservoir as a potential source of
the epidemics, although the
researchers could not identify a par-
ticular species as the specific source.
Miguel G. Madariaga*
*University of Nebraska Medical Center,
Omaha, Nebraska, USA
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